|
GLPG 0974
|
|
1391076-61-1
|
|
Gefitinib-based PROTAC 3
|
|
2230821-27-7
|
|
GSHtracer
|
|
1479071-34-5
|
|
GSK 2837808A
|
|
1445879-21-9
|
|
G 28UCM
|
|
1094451-90-7
|
|
GN 44028
|
|
1421448-26-1
|
|
Gap19
|
|
1507930-57-5
|
|
Goserelin acetate
|
|
145781-92-6
|
|
GTP 14564
|
|
34823-86-4
|
|
GA3-AM
|
|
1373154-68-7
|
|
Gavestinel
|
|
153436-38-5
|
|
GSK 269962
|
|
850664-21-0
|
|
GSK 5959
|
|
901245-65-6
|
|
GRI 977143
|
|
325850-81-5
|
|
GSK 4112
|
|
1216744-19-2
|
|
Ginsenoside F1
|
|
53963-43-2
|
|
gamma-Mangostin
|
|
31271-07-5
|
|
Glycocholic acid hydrate
|
|
1192657-83-2
|
|
Glutaconic acid
|
|
1724-02-3
|
|
Gly-gly-leu
|
|
14857-82-0
|
|
GMX1778
|
|
200484-11-3
|
|
Gly-Gln monohydrate
|
|
172669-64-6
|
|
Glycidyl 4-methoxyphenyl ether
|
|
2211-94-1
|
|
4-(2-Naphthyl)-4-oxobutanoic acid
|
|
1590-22-3
|
|
GR127935 hydrochloride
|
|
148642-42-6
|
|
Glycolaldehyde dimer
|
|
23147-58-2
|
|
Gilteritinib
|
|
1254053-43-4
|
|
Ginsenoside Compound K
|
|
39262-14-1
|
|
Geranic acid
|
|
459-80-3
|
|
Gemifloxacin mesylate
|
|
210353-53-0
|
|
GI254023X
|
|
260264-93-5
|
|
GSK2578215A
|
|
1285515-21-0
|
|
GNF-7
|
|
839706-07-9
|
|
Graphite, fluorinated, polymer
|
|
51311-17-2
|
|
Gatifloxacin Hydrate
|
|
614751-80-3
|
|
N-Glycylglycine ethyl ester hydrochloride
|
|
2087-41-4
|
|
20(R)-Ginsenoside Rh2
|
|
112246-15-8
|
|
GANT58
|
|
64048-12-0
|
|
Tenofovir alafenamide
|
|
379270-37-8
|
|
GW7647
|
|
265129-71-3
|
|
GSK6853
|
|
1910124-24-1
|
|
GSK 4716
|
|
101574-65-6
|
|
D-Glucopyranose, oligomeric, C9-11-alkyl glycoside
|
|
132778-08-6
|
|
GANT 61
|
|
500579-04-4
|
|
GR 46611
|
|
185259-85-2
|
|
GBR 12909 dihydrochloride
|
|
67469-78-7
|
|
GDC-0941 dimesylate
|
|
957054-33-0
|
|
Glycohyodeoxycholic acid
|
|
13042-33-6
|
|
GYY 4137
|
|
106740-09-4
|
|
Ginsenoside Rg3
|
|
38243-03-7
|
|
GM 6001
|
|
142880-36-2
|
|
Glycyl-L-Histidyl-L-Lysine
|
|
49557-75-7
|
|
Ghrelin (human) (acetate)
|
|
258279-04-8
|
|
GBR 13069 dihydrochloride
|
|
67469-45-8
|
|
GF 109203X hydrochloride
|
|
176504-36-2
|
|
GMQ hydrochloride
|
|
5361-15-9
|
|
Glycinamide
|
|
598-41-4
|
|
GSK-J2
|
|
1394854-52-4
|
|
Ginsenoside F2
|
|
62025-49-4
|
|
GSK-1016790A
|
|
942206-85-1
|
|
GS 39783
|
|
39069-52-8
|
|
Gp 1a
|
|
511532-96-0
|
|
Glyceryl monostearate
|
|
31566-31-1
|
|
GTS-21 dihydrochloride (DMBX-A)
|
|
156223-05-1
|
|
Glucaric acid calcium salt (Calcium saccharate)
|
|
5793-89-5
|
|
Gap26 trifluoroacetate
|
|
197250-15-0
|
|
Go 6976
|
|
136194-77-9
|
|
Guggulsterone（pregna-4,17-diene-3,16-dione）
|
|
95975-55-6
|
|
GSK484 hydrochloride
|
|
1652591-81-5
|
|
GSK503
|
|
1346572-63-1
|
|
STING agonist-1
|
|
702662-50-8
|
|
GSK872
|
|
1346546-69-7
|
|
GSK-J4
|
|
1373423-53-0
|
|
Gap 27（TFA)
|
|
198284-64-9
|
|
Grubbs Catalyst M800
|
|
1383684-54-5
|
|
GTP-γ-S-Li4
|
|
94825-44-2
|
|
GNE7915
|
|
1351761-44-8
|
|
GSK2656157
|
|
1337532-29-2
|
|
Gadolinium(III) chloride hydrate
|
|
19423-81-5
|
|
GppNHp
|
|
64564-03-0
|
|
Gold(I) iodide
|
|
10294-31-2
|
|
GNE 2861
|
|
1394121-05-1
|
|
G-1
|
|
881639-98-1
|
|
GGsTop
|
|
926281-37-0
|
|
GSK 2239633A
|
|
1240516-71-5
|
|
GSK 650394
|
|
890842-28-1
|
|
GSK 137647
|
|
349085-82-1
|
|
GS 6201
|
|
752222-83-6
|
|
GRL 0617
|
|
1093070-16-6
|
|
GSK 2193874
|
|
1336960-13-4
|
|
GT 949
|
|
460330-27-2
|
|
GSK 583
|
|
1346547-00-9
|
|
|
Grubbs Catalyst? M202为 Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene](3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium(II)
|
536724-67-1
|
|
GSK 591 dihydrochloride
|
|
2320953-89-5
|
|
GS 441524
|
|
1191237-69-0
|
|
GBR 12935 dihydrochloride
|
|
67469-81-2
|
|
G-15
|
|
1161002-05-6
|
|
GSK 2830371
|
|
1404456-53-6
|
|
GNF 5837
|
|
1033769-28-6
|
|
GR 89696 fumarate
|
|
126766-32-3
|